Annual Total Liabilities
$6.03 M
+$811.20 K+15.54%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual total liabilities is $6.03 million, with the most recent change of +$811.20 thousand (+15.54%) on December 31, 2023.
- During the last 3 years, GANX annual total liabilities has risen by +$2.63 million (+77.26%).
- GANX annual total liabilities is now at all-time high.
Performance
GANX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$5.46 M
-$1.96 M-26.38%
September 30, 2024
Summary
- As of February 12, 2025, GANX quarterly total liabilities is $5.46 million, with the most recent change of -$1.96 million (-26.38%) on September 30, 2024.
- Over the past year, GANX quarterly total liabilities has dropped by -$574.80 thousand (-9.53%).
- GANX quarterly total liabilities is now -26.38% below its all-time high of $7.41 million, reached on June 30, 2024.
Performance
GANX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
GANX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.5% | -9.5% |
| 3 y3 years | +77.3% | +30.9% |
| 5 y5 years | - | +30.9% |
GANX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.7% | -26.4% | +30.9% |
| 5 y | 5-year | at high | +443.3% | -26.4% | +60.4% |
| alltime | all time | at high | +443.3% | -26.4% | +60.4% |
Gain Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.46 M(-26.4%) |
| Jun 2024 | - | $7.41 M(+24.9%) |
| Mar 2024 | - | $5.94 M(-1.6%) |
| Dec 2023 | $6.03 M(+15.5%) | $6.03 M(-10.9%) |
| Sep 2023 | - | $6.77 M(-5.6%) |
| Jun 2023 | - | $7.17 M(+15.9%) |
| Mar 2023 | - | $6.18 M(+18.5%) |
| Dec 2022 | $5.22 M | $5.22 M(-7.8%) |
| Sep 2022 | - | $5.66 M(+16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $4.87 M(-15.6%) |
| Mar 2022 | - | $5.77 M(+38.5%) |
| Dec 2021 | $4.17 M(+22.5%) | - |
| Dec 2021 | - | $4.17 M(-16.9%) |
| Sep 2021 | - | $5.02 M(+26.6%) |
| Jun 2021 | - | $3.96 M(+10.8%) |
| Mar 2021 | - | $3.58 M(+5.1%) |
| Dec 2020 | $3.40 M(+206.5%) | - |
| Dec 2020 | - | $3.40 M |
| Dec 2019 | $1.11 M | - |
FAQ
- What is Gain Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Gain Therapeutics?
- What is Gain Therapeutics annual total liabilities year-on-year change?
- What is Gain Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Gain Therapeutics?
- What is Gain Therapeutics quarterly total liabilities year-on-year change?
What is Gain Therapeutics annual total liabilities?
The current annual total liabilities of GANX is $6.03 M
What is the all time high annual total liabilities for Gain Therapeutics?
Gain Therapeutics all-time high annual total liabilities is $6.03 M
What is Gain Therapeutics annual total liabilities year-on-year change?
Over the past year, GANX annual total liabilities has changed by +$811.20 K (+15.54%)
What is Gain Therapeutics quarterly total liabilities?
The current quarterly total liabilities of GANX is $5.46 M
What is the all time high quarterly total liabilities for Gain Therapeutics?
Gain Therapeutics all-time high quarterly total liabilities is $7.41 M
What is Gain Therapeutics quarterly total liabilities year-on-year change?
Over the past year, GANX quarterly total liabilities has changed by -$574.80 K (-9.53%)